Stock Updates

Is this Large Market Cap Stock target price reasonable for The Medicines Company (NASDAQ:MDCO)?

The company in question is, The Medicines Company (NASDAQ:MDCO) currently with a stock price of 35.5 (-0.84% today). The market cap for The Medicines Company is 2520.32, and is in the sector Healthcare, and Drugs – Generic industry. The target price for The Medicines Company is 50.05. Currently The Medicines Company is trading with a P/E of *TBA, and a forward P/E of *TBA. Average volume for The Medicines Company is 927.31 and so far today it is 567808.

Performance in the last year for The Medicines Company has been 4.86%. For EPS growth, The Medicines Company has seen a growth of 74.20%, and is looking to grow in the next year to -244.90%. More long term stats show that EPS growth has been -29.80% over the last five years and could be *TBA for the next five years. The Medicines Company has seen sales growth quarter over quarter at -26.60%, with EPS growth quarter over quarter at 345.00%. The 20-day simple moving average is -7.16%, with the 200-day simple moving average coming to 0.48%.

Since the IPO date for The Medicines Company on the 08/08/2000, The Medicines Company has seen performance year to date to be -4.12%. With The Medicines Company trading at 35.5, the dividend yield is *TBA, and the EPS is -1.16.

So could The Medicines Company, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 10.99 and the P/B is at 3. The P/cash is 3.91, with P/free cash flow at *TBA.

The Medicines Company ability to deal with debt shows that the current ratio is 3.6, and the quick ratio is 3.2. This is with long term debt/equity at 0.74, and total debt/equity at 0.8.

In terms of margins, The Medicines Company has a gross margin of 52.60%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for The Medicines Company is *TBA. Return on assets come to *TBA with return on investment coming to -18.10%.

Insider ownership for The Medicines Company, is at 1.70% and institutional ownership comes to *TBA. Outstanding shares are at 70.4. While shares float is 68.42. The float short is currently 16.39%, and short ratio is 12.09.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment